RAFAEL
RUBIO GARCÍA
Profesor titular de universidad
RAFAEL
DELGADO VÁZQUEZ
Profesor titular de universidad
Publicacións nas que colabora con RAFAEL DELGADO VÁZQUEZ (17)
2022
-
Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance
Open Forum Infectious Diseases, Vol. 9, Núm. 11
2021
-
Detection of archived lamivudine-associated resistance mutations in virologically suppressed, lamivudine-experienced HIV-infected adults by different genotyping techniques (GEN-PRO study)
Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 12, pp. 3263-3271
-
Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study
The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 3, pp. 738-742
2020
-
Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound
Scientific Reports, Vol. 10, Núm. 1
2018
-
Analysis of drug resistance mutations in whole blood DNA from HIV-1 infected patients by single genome and ultradeep sequencing analysis
Journal of Virological Methods, Vol. 260, pp. 1-5
2016
2015
-
Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5
-
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5
2014
-
Different trends of transmitted HIV-1 drug resistance in Madrid, Spain, among risk groups in the last decade
Archives of Virology, Vol. 159, Núm. 5, pp. 1079-1087
2012
-
Lack of the detection of XMRV or polytropic MLV-related sequences in blood cells from HIV-1-infected patients in spain
Journal of Acquired Immune Deficiency Syndromes, Vol. 59, Núm. 2, pp. 101-104
2010
-
Detection of HIV-1 at between 20 and 49 copies per milliliter by the Cobas TaqMan HIV-1 v2.0 assay is associated with higher pretherapy viral load and less time on antiretroviral therapy
Journal of Clinical Microbiology, Vol. 48, Núm. 5, pp. 1911-1912
2009
-
HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations
Journal of Antimicrobial Chemotherapy, Vol. 64, Núm. 2, pp. 251-258
-
Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-Week analysis
Journal of Acquired Immune Deficiency Syndromes, Vol. 51, Núm. 2, pp. 147-152
-
Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression
Antiviral Therapy, Vol. 14, Núm. 2, pp. 195-201
2008
2001
-
GESIDA Consensus document on the use of resistance studies in clinical practice
Enfermedades infecciosas y microbiología clínica